Introduction
More than a decade ago, those of us in the neurotherapy field gathered just after Christmas holidays for the yearly Future Health Winter Brain Conference. Although most of what went on was chest beating about our remarkable accomplishments, I chaired a session each year on ''train wrecks'' in therapy. Anecdotally, it was interesting to me to see just which of my renowned friends and colleagues had the chutzpah to unabashedly reveal their failures. Many, while starting out describing a less than optimal therapeutic outcome, shifted gears and described how they rescued this difficult situation and emerged victorious. We all have failures, but it is not neurotherapy that fails. In my opinion, neurotherapy always works. Why we fail is because we miss something in the therapeutic alliance. Neurotherapy doesn't fail-we do! In the next few pages I will discuss a few circumstances that can compromise effective neurotherapeutic treatment.
Family Dynamics
I never cease to be amazed at how easily I fall into the trap of not recognizing an underlying family problem that is either causing or sustaining a child's problems with academic achievement. Part of this, I assume, is my tendency to rely so very heavily on what the brain tells me about difficulties that are neurological in nature.
I also err on the side of accepting parental assessments of the child's condition as being reasonably accurate. The data are quite clear, however, that parents with mood disorders have biased ratings of their children's psychopathology and behavior problems (Maoz et al., 2014) . Some family dynamic issues are not easy to spot. The one that I trip up on routinely is the situation in which the child must remain symptomatic to satisfy some need within the family.
Jason was a 13-year-old boy that I treated almost 20 years ago. His case is one that always comes back to my mind when I find myself again missing this most fundamental family dynamic problem. Jason was doing okay in school. He had mostly Cs, a smattering of Bs, and the occasional A. His family reported that Jason was not able to achieve at a level consistent with his capabilities, a sentiment to which Jason readily agreed.
Jason's EEG showed a mild elevation of the theta/beta ratio over the central part of the brain (the CADD profile; Swingle, 2001 ), but no other remarkable EEG features that would be associated with academic difficulties.
Jason was the kind of child in whom I felt rather confident that we would be able to help within 10 or 15 sessions or so, restoring the theta/beta ratio to normal levels so the child could function more efficiently and with less effort. Jason responded very well to neurotherapeutic treatment. Within about eight sessions, the theta/beta ratio was very close to normative level, and within about another six sessions he was comfortably below the clinical cutoff for the CADD problem.
Jason reported that he felt he was doing much better in school and found homework easier to complete. Jason was using the Omni harmonic, a therapeutic sound that suppresses slow frequency amplitude (Swingle, 2015a) , every night while he was doing homework and he found it very helpful for sustaining focus and attention. Jason proudly brought in his report card for me to see. His report card had just one C, and the rest of the grades were Bs and As! So was this a treatment success? Get out the ''cured'' stamp, parents now happy, and refer many other parents to bring their children for treatment in our clinic, receive a letter from the child a few years later proudly reporting on his successes? I'm afraid not! The next day I received a phone call from Jason's mother asking, ''Isn't there anything we can do about Jason's ADD? I think we must put him on medication.'' It's perfectly clear that I missed something here. And it certainly should have been family therapy time. Jason's parents came in to see me, one at a time; they did not come in together. I should have been more curious about this, but made the assumption that schedules did not permit them to come together. It turns out that, although the parents were still living in the same house together, separation and divorce had been a topic of conversation for years. From a family dynamic perspective, it appeared as though Jason had to remain in some sense problematic, if not disabled, in order to hold the family together. The father recognized this dynamic and felt that there was an unreasonable focus on Jason's condition, which he did not feel was markedly problematic. Jason confirmed that his mother focused on his academic difficulties. He said that his mother frequently asked him if he found his work very difficult, if he was getting excessively tired, and she would focus attention on how difficult this was for him. Jason apparently acquiesced to this and would indicate that he felt he was exhausted and was working very hard to accomplish his grades.
There were several very important features of this case. First, Jason's EEG assessment did not reflect the family crisis. There was no alpha blunting at any of the locations, nor was there any hyper-vigilance pattern. It could well be that Jason did not feel the brunt of his parents' conflict in the sense of feeling insecure, or even recognize that separation of his parents was a decided possibility. In fact, Jason may have felt quite secure, given his mother's hovering over him and rewarding his belief that he was working more diligently and overcoming more obstacles than his classmates.
Illicit Drugs
Neuropsychologically, acute intoxication with cannabis has most consistently demonstrated retrieval-based memory problems. Imaging studies in human adolescents show that regular marijuana users display impaired neural connectivity in specific brain regions involved in a broad range of executive functions like memory, learning, and impulse control compared to nonusers (Batalla et al., 2013; Meier et al., 2012 ; National Institute on Drug Abuse [NIDA], 2014a).
FMRI indicates that heavy use of cannabis alters brain activity in regions linked to the motivational and affective aspects of decision making in the ventromedial prefrontal cortex (VMPFC), the orbitofrontal cortex, and the insula. In this regard, it has been demonstrated that substancedependent individuals and patients with VMPFC lesions exhibit similar behaviors that lead them to make similar decisions in real life, preferring choices that bring immediate benefits even if coupled with negative consequences (Bechara & Damasio, 2002) .
Adolescents who are regular marijuana users are poor candidates for effective neurotherapy unless the issue of the drug use is faced head-on. A major problem, in my experience, is when parents turn a blind eye to the problem and much worse when they tacitly endorse use. For example, to quote one parent, ''he uses marijuana to calm himself-it helps him with school to reduce his anxiety.'' Whether or not I see a suspicious QEEG pattern, I always query the child, privately, about marijuana use and provide some simple basic facts (e.g., ''It'll make you stupid!'').
When I see a suspicious pattern, such as with Johnny (see Figure 1) , I then make a direct statement (again privately): ''Stop smoking dope-don't say yea or nay-if you are not, great, if you are then stop. . . .'' The child is usually so stunned that I can see this in his ''brain map'' in addition to being stunningly accurate about his other conditions, that I often get good rapport, transparency, and marked reduction or abstinence, in drug use. These children then become excellent clients and respond well to neurotherapy and related psychological treatments that may be required. As shown in Figure 1 (see data in bold type), Johnny has the form of ADHD associated with elevated theta/beta ratio at Cz, which becomes more problematic under task conditions, such as reading. However, he also shows elevated theta/beta under eyes-closed condition at location O1 and substantial slowing of alpha indicated by the elevated ratio of slow to fast alpha at location Fz. These are the indicators that lead to my suspicion of marijuana use (admittedly, in Vancouver I was likely to be correct more than 50% of the time anyway!).
Medical Drugs
Cognitive impairments associated with prescription medications are well established (Evans & Golomb, 2009) . It is a common misconception that abusing prescription medications is safer than taking illegal street drugs. Abusing prescription medications is very dangerous, and can even be With patients as well as health care practitioners, I find it often very problematic to effectively treat such clients because of these misconceptions. They often deny dependency, have the tacit approval of the prescribing physicians (often multiple prescribers), and are not transparent about efforts to titrate off the medications. I have found that often prescribers are unaware of other prescribers, and clients are frequently reluctant to provide authorization for the various treaters to communicate among themselves. Clients will mislead by maintaining that they are reducing the amount of medications they are taking and can be vague regarding the degree of medical supervision they are receiving regarding their medication regimen. Figures 2  and 3 show some interesting data on one of my train wrecks. Figure 2 shows a clip from the RateMD website with ratings from four consecutive clients rating yours truly. The last rating is that from a maxed-out prescription addict. She had a long history of pharmaceutical cocktails, claimed that these medications had provided minimal relief, wanted to discontinue the medications, and had started the titration process under direct medical supervision. She had a total of 17 sessions (not 30) and I know her identity and her neurological (EEG) data. As the reader will note, she is not what we therapists call a ''happy camper,'' and she claims that all of the clients she met at the Clinic had the same experience as she-namely, that I don't deliver on my promises. Figure 3 shows data from an aggressive brain driving session with this client to reduce beta amplitude at location O1. As the reader will note, the brain did not budge. Typically, with an unchemicalized brain, such braindriving protocols result in a minimum of 10% change and many show changes markedly above that level. This particular session is one of the worst I have seen-the EEG was virtually unchanged.
My mistake? I did not insist on direct communication with all of the prescribing physicians and secondarily should have arranged for someone among the providers to be ''quarterback'' for this client. I relied on what this client told me. Note that she received the neurofeedback sessions over a 3-year period. She came to have a few ''feel good'' sessions and then stopped treatment, perhaps because the medications became temporally more effective (Arns, Drinkenburg, Fitzgerald, & Kenemans, 2012) . She then returned for a few more sessions when she became more troubled, which in turn, became less effective when she then terminated permanently. Although all therapists are tempted to label such clients ''treatment resistant'' or ''bald faced liars,'' I always force myself to admit that I screwed up! I did not build the treatment team properly and I did not have the therapeutic alliance required to meaningfully help this very problematic client. In our parlance, ''I did not get the hook in securely.'' Client Based vs. One-Size-Fits-All
There are many other factors that impede effective neurotherapy treatment. I have my own pet peeves including the one-size-fits-all ''therapists'' who damage the field. Often these practitioners are unlicensed franchisees who rely exclusively on top-down (symptom to protocol) methodologies that simply miss the mark (Swingle, 2014 (Swingle, , 2015a Train Wrecks and Other Things 2015b). I liken these treatments to the stationary bicycle in the fitness gyms. Will you have benefit from exclusive use of the bicycle? Certainly, but not what the science has to offer. The flip side of this one-size-fits-all boondoggle is the notion that reducing the number of variations from normative connectivity (the z-score, bop-bop protocols) will resolve all clients' complaints when used as an exclusive therapy. There are no ''horse race'' studies that have been done to demonstrate how such methodologies can be effectively integrated into client care. I use them to prime the pump, in some cases, and to destabilize when I run into situations (like the prescription drug addict client discussed above) in which I am not getting satisfactory effects with the neurotherapy.
Emotional Trauma
My most compelling concern is that we may underestimate, or miss entirely, emotional trauma in children that causes symptomology that does not fully respond to neurotherapeutic treatment. McLaughlin et al. (2013) report that in a sample of over 6,000 adolescents, a startling 61% reported exposure to at least one potentially traumatic event, including rape, physical abuse, domestic violence, death of close friend or family member, and natural disasters (Swingle & Swingle, 2016 , also discuss this topic Swingle in a second article in this issue of Biofeedback). Almost 20% of these children reported three or more such exposures. Of this 61%, 7.3% of female and 2.2% of male adolescents fit diagnostic criteria for post-traumatic stress disorder (PTSD), a rate similar to that of U.S. adults.
Case Narrative: A Child in Crisis I close with a case of a child that we designate CIC (child in crisis) in our clinic (see Figure 4) . This child's ClinicalQ (see data in bold type) shows both trauma markers (blunted eyes-closed alpha at locations O1 and Cz), poor stress tolerance (low theta/beta at O1), severe anxiety markers (elevated beta at F3, F4, and Fz), frontal blunting (elevated delta at Fz, often found with significant emotional trauma), and perseverative thought processes (elevated 28-40 Hz amplitude at Fz).
So, what do we need for this child in addition to neurotherapy? As I often state, ''Neurotherapy is not a stand-alone discipline.'' This child was experiencing a major trauma. Her father was diagnosed with terminal cancer and had a short time to live. The parents tried to keep an unkeepable secret from this 7-year-old child. 
Train Wrecks and Other Things

Use of The Healing Circle
Children, and adopted children in particular, commonly show symptoms associated with attachment and abandonment issues and the related neurological markers similar to those shown above. However, we must keep in mind that about 40% of children with these conditions often appear asymptomatic. We do know, however, that family communication and attachment can reduce the impact of the potentially traumatic event (Belsky, 2010; Elgar et al., 2014; Raby, Roisman, Fraley, & Simpson, 2014) . Elgar et al. (2014) , for example, found that the more family dinners per week reported by children victimized by cyberbullying, the less symptomatic the child. Hence, one of the home-based procedures that many of my families find very helpful is the healing circle practiced in some aboriginal groups.
In a healing circle, as I understand it, people sit around the campfire with the talking stick. The stick is passed from one person to another and when you are in possession of the talking stick, you have the unchallengeable right to speak. Other members can only express agreement or acknowledgment. That is, they can say ''yes'' or ''I understand.'' Nothing more! The speaker only talks about his or her own feelings. 
Conclusion
It is important for the therapist to be aware of all of the issues that can interfere with successful outcomes in neurotherapy. Neurotherapy is not a stand-alone therapy. Most often, truly successful treatment requires supportive additional therapy adjunctive to the neurotherapy. Unrecognized family dynamics and traumatic family events frequently contribute to treatment setbacks in neurofeedback. Failure to recognize key factors currently influencing a patient or a family member, such as street drug use or abuse of prescription medications, is hazardous for treatment. If we recognize the influences at work and engage the patient successfully in addressing the problems, treatment can often be successful. As mentioned at the start of this paper, ''Why we fail is because we miss something in the therapeutic alliance.'' Neurotherapy doesn't fail-we do!
